441 related articles for article (PubMed ID: 16530171)
41. Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment.
Posa L; Accarie A; Noble F; Marie N
Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26390873
[TBL] [Abstract][Full Text] [Related]
42. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo.
Endoh T; Matsuura H; Tanaka C; Nagase H
Arch Int Pharmacodyn Ther; 1992; 316():30-42. PubMed ID: 1326932
[TBL] [Abstract][Full Text] [Related]
43. Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels.
Watkins LR; Wiertelak EP; Maier SF
Brain Res; 1992 Jun; 582(1):10-21. PubMed ID: 1323369
[TBL] [Abstract][Full Text] [Related]
44. Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands.
Shippenberg TS; Herz A
J Pharmacol Exp Ther; 1991 Mar; 256(3):1101-6. PubMed ID: 1848627
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological characterization of [D-Ala2,Leu5,Ser6]enkephalin (DALES): antinociceptive actions at the delta non-complexed-opioid receptor.
Mattia A; Vanderah T; Mosberg HI; Omnaas JR; Bowen WD; Porreca F
Eur J Pharmacol; 1991 Jan; 192(3):371-5. PubMed ID: 1647317
[TBL] [Abstract][Full Text] [Related]
46. Phenylmorphans and analogues: opioid receptor subtype selectivity and effect of conformation on activity.
Froimowitz M; Pick CG; Pasternak GW
J Med Chem; 1992 May; 35(9):1521-5. PubMed ID: 1315868
[TBL] [Abstract][Full Text] [Related]
47. Clonidine, administered intracerebroventricularly in mice, produces an anti-analgesic effect which may be mediated spinally by dynorphin A (1-17).
Fujimoto JM; Arts KS
Neuropharmacology; 1990 Apr; 29(4):351-8. PubMed ID: 1971432
[TBL] [Abstract][Full Text] [Related]
48. Involvement of spinal cord opioid mechanisms in the acute antinociceptive effect of hyperbaric oxygen in mice.
Heeman JH; Zhang Y; Shirachi DY; Quock RM
Brain Res; 2013 Dec; 1540():42-7. PubMed ID: 24113418
[TBL] [Abstract][Full Text] [Related]
49. Affective defense behavior elicited from the feline midbrain periqueductal gray is regulated by mu and delta opioid receptors.
Shaikh MB; Lu CL; Siegel A
Brain Res; 1991 Aug; 557(1-2):344-8. PubMed ID: 1660757
[TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505.
Dietis N; Niwa H; Tose R; McDonald J; Ruggieri V; Filaferro M; Vitale G; Micheli L; Ghelardini C; Salvadori S; Calo G; Guerrini R; Rowbotham DJ; Lambert DG
Br J Pharmacol; 2018 Jul; 175(14):2881-2896. PubMed ID: 29524334
[TBL] [Abstract][Full Text] [Related]
51. Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord.
Song SH; Takemori AE
Life Sci; 1992; 51(2):107-11. PubMed ID: 1352026
[TBL] [Abstract][Full Text] [Related]
52. The Role of Opioid Receptor Antagonists in Regulation of Blood Pressure and T-Cell Activation in Mice Selected for High Analgesia Induced by Swim Stress.
Skiba D; Jaskuła K; Nawrocka A; Poznański P; Łazarczyk M; Szymański Ł; Żera T; Sacharczuk M; Cudnoch-Jędrzejewska A; Gaciong Z
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473865
[TBL] [Abstract][Full Text] [Related]
53. Serotonin contributes to the spinal antinociceptive effects of morphine.
Crisp T; Stafinsky JL; Uram M; Perni VC; Weaver MF; Spanos LJ
Pharmacol Biochem Behav; 1991 Jul; 39(3):591-5. PubMed ID: 1686100
[TBL] [Abstract][Full Text] [Related]
54. Low doses of acetaminophen produce antidepressive-like effects through the opioid system in mice.
Ghorbanzadeh B; Azizolahi B; Masoudipur F; Boroun A; Azizi M; Oroojan AA; Jafrasteh S
Behav Brain Res; 2024 Jul; 469():115065. PubMed ID: 38782097
[TBL] [Abstract][Full Text] [Related]
55. Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder.
Zheng Y; Obeng S; Reinecke BA; Chen C; Phansalkar PS; Walentiny DM; Gerk PM; Liu-Chen LY; Selley DE; Beardsley PM; Zhang Y
Eur J Pharmacol; 2019 Dec; 865():172812. PubMed ID: 31743739
[TBL] [Abstract][Full Text] [Related]
56. Evidence that opioids may have toll-like receptor 4 and MD-2 effects.
Hutchinson MR; Zhang Y; Shridhar M; Evans JH; Buchanan MM; Zhao TX; Slivka PF; Coats BD; Rezvani N; Wieseler J; Hughes TS; Landgraf KE; Chan S; Fong S; Phipps S; Falke JJ; Leinwand LA; Maier SF; Yin H; Rice KC; Watkins LR
Brain Behav Immun; 2010 Jan; 24(1):83-95. PubMed ID: 19679181
[TBL] [Abstract][Full Text] [Related]
57. Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice.
Bagdas D; Muldoon PP; AlSharari S; Carroll FI; Negus SS; Damaj MI
Neuropharmacology; 2016 Mar; 102():236-43. PubMed ID: 26639043
[TBL] [Abstract][Full Text] [Related]
58. Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists.
Maldonado R; Negus S; Koob GF
Neuropharmacology; 1992 Dec; 31(12):1231-41. PubMed ID: 1335131
[TBL] [Abstract][Full Text] [Related]
59. Evidence for the involvement of the mu but not delta opioid receptor subtype in the synergistic interaction between opioid and alpha 2 adrenergic antinociception in the rat spinal cord.
Sullivan AF; Kalso EA; McQuay HJ; Dickenson AH
Neurosci Lett; 1992 May; 139(1):65-8. PubMed ID: 1357605
[TBL] [Abstract][Full Text] [Related]
60. Coincident Regulation of PLC
Sanchez GA; Jutkiewicz EM; Ingram S; Smrcka AV
Mol Pharmacol; 2022 Dec; 102(6):269-279. PubMed ID: 36116788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
